AVITA Medical (AVHHL) EBITDA Margin (2018 - 2026)
AVITA Medical's (AVHHL) quarterly EBITDA Margin came in at 31.59% in Q2 2026, up 2894.0% on a YoY basis from 1.06% in Q2 2025, and down 179.21% quarter-over-quarter from 11.31% in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) EBITDA Margin (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported EBITDA Margin for 9 consecutive years, with 31.59% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 2894.0% year-over-year to 31.59%; the trailing twelve-month figure through Jun 2026 stood at 25.18% (up 3723.0% YoY), and the FY2025 full-year result was 59.4%, up 2868.0% from the prior year.
- EBITDA Margin eased to 31.59% in Q2 2026 per AVHHL's latest filing, from 11.31% in the prior quarter.
- Across five years, EBITDA Margin topped out at 11.31% in Q4 2025 and bottomed at 154.95% in Q1 2024.
- Historically, EBITDA Margin has averaged 77.55% across 5 years, with a median of 69.42% in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin sank 6101 bps in 2024, then soared 9107 bps in 2025.
- Over 5 years, EBITDA Margin stood at 104.71% in 2022, then rose by 17 bps to 86.46% in 2023, then soared by 37 bps to 54.1% in 2024, then jumped by 79 bps to 11.31% in 2025, then plunged by 179 bps to 31.59% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 31.59%, 11.31%, and 53.65% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 19.15% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | -31.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.59% |
| Dec 31, 2025 | -11.31% |
| Sep 30, 2025 | -53.65% |
| Jun 30, 2025 | -60.53% |
| Mar 31, 2025 | -63.88% |
| Dec 31, 2024 | -54.10% |
| Sep 30, 2024 | -70.63% |
| Jun 30, 2024 | -102.82% |
| Mar 31, 2024 | -154.95% |
| Dec 31, 2023 | -86.46% |
| Sep 30, 2023 | -68.20% |
| Jun 30, 2023 | -95.00% |
| Mar 31, 2023 | -93.94% |
| Dec 31, 2022 | -104.71% |
| Sep 30, 2022 | -63.22% |
| Mar 31, 2022 | -125.84% |
| Sep 30, 2021 | -63.80% |
| Jun 30, 2021 | -56.09% |
| Mar 31, 2021 | -68.35% |
| Dec 31, 2020 | -110.35% |